$2.67 Billion is the total value of SABBY MANAGEMENT, LLC's 307 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 113.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | SPDR S&P 500 ETF TRUSTput | $302,820,000 | +71.7% | 14,000 | +66.4% | 11.34% | +23.3% | |
New | SPDR S&P 500 ETF TRUSTcall | $216,300,000 | – | 10,000 | +100.0% | 8.10% | – | |
New | ISHARES RUSSELL 2000put | $184,973,000 | – | 14,892 | +100.0% | 6.93% | – | |
New | GILEAD SCIENCES INCcall | $92,499,000 | – | 11,691 | +100.0% | 3.46% | – | |
Buy | REGENERON PHARMACEUTICALS INCput | $72,042,000 | +77.8% | 1,792 | +54.5% | 2.70% | +27.7% | |
New | ISHARES RUSSELL 2000call | $67,583,000 | – | 5,441 | +100.0% | 2.53% | – | |
Buy | MONSANTO COcall | $57,304,000 | +3.9% | 5,607 | +5.1% | 2.15% | -25.4% | |
New | AMGEN INCput | $42,853,000 | – | 2,569 | +100.0% | 1.60% | – | |
Buy | ELI LILLY & COput | $39,311,000 | +2.1% | 4,898 | +0.1% | 1.47% | -26.7% | |
Buy | CELGENE CORPcall | $36,073,000 | +426.2% | 3,451 | +396.5% | 1.35% | +277.4% | |
REGN | Buy | REGENERON PHARMACEUTICALS INC | $30,521,000 | +22.2% | 75,919 | +6.1% | 1.14% | -12.3% |
New | BRISTOL MYERS SQUIBB CO.call | $29,165,000 | – | 5,409 | +100.0% | 1.09% | – | |
Buy | ALKERMES PLCcall | $28,201,000 | +255.6% | 3,249 | +143.4% | 1.06% | +155.3% | |
New | MERCK & CO INCcall | $28,003,000 | – | 4,487 | +100.0% | 1.05% | – | |
Buy | CELGENE CORPput | $25,244,000 | +3226.0% | 2,415 | +3036.4% | 0.95% | +2265.0% | |
New | ACADIA PHARMACEUTICALS INCcall | $24,761,000 | – | 7,784 | +100.0% | 0.93% | – | |
New | AGIOS PHARMACEUTICALS INCcall | $21,698,000 | – | 4,108 | +100.0% | 0.81% | – | |
Buy | CLOVIS ONCOLOGY INCcall | $21,089,000 | +845.3% | 5,850 | +259.8% | 0.79% | +581.0% | |
New | EXPRESS SCRIPTS HOLDING COcall | $20,433,000 | – | 2,897 | +100.0% | 0.77% | – | |
New | BRISTOL MYERS SQUIBB CO.put | $18,705,000 | – | 3,469 | +100.0% | 0.70% | – | |
Buy | VERTEX PHARMACEUTICALS INCcall | $17,050,000 | +225.4% | 1,955 | +221.0% | 0.64% | +134.1% | |
Buy | CEMPRA INCput | $15,302,000 | +296.5% | 6,323 | +170.2% | 0.57% | +185.1% | |
Buy | PUMA BIOTECHNOLOGY INCcall | $13,551,000 | +893.5% | 2,021 | +341.3% | 0.51% | +615.5% | |
New | UNITED THERAPEUTICS CORPput | $12,965,000 | – | 1,098 | +100.0% | 0.49% | – | |
Buy | SPDR SERIES TRUSTput | $12,980,000 | +29.2% | 1,958 | +5.4% | 0.49% | -7.3% | |
New | HUMANA INCput | $12,382,000 | – | 700 | +100.0% | 0.46% | – | |
New | EXPRESS SCRIPTS HOLDING COput | $11,927,000 | – | 1,691 | +100.0% | 0.45% | – | |
New | ASTRAZENECA PLCcall | $11,567,000 | – | 3,520 | +100.0% | 0.43% | – | |
Buy | LEXICON PHARMACEUTICALS INCcall | $11,317,000 | +48.2% | 6,263 | +17.7% | 0.42% | +6.5% | |
New | HESS CORPcall | $11,040,000 | – | 2,059 | +100.0% | 0.41% | – | |
Buy | DEPOMED INCcall | $10,798,000 | +598.4% | 4,321 | +448.4% | 0.40% | +400.0% | |
Buy | ALNYLAM PHARMACEUTICALS INCcall | $9,815,000 | +79.2% | 1,448 | +46.7% | 0.37% | +28.7% | |
ONS | Buy | ONCOBIOLOGICS INC | $9,643,000 | +37.1% | 2,268,585 | +9.6% | 0.36% | -1.6% |
New | BLUEBIRD BIO INCcall | $9,354,000 | – | 1,380 | +100.0% | 0.35% | – | |
BMY | New | BRISTOL MYERS SQUIBB CO. | $8,459,000 | – | 156,887 | +100.0% | 0.32% | – |
Buy | DYNAVAX TECHNOLOGIES CORPput | $8,002,000 | -7.6% | 7,628 | +28.4% | 0.30% | -33.6% | |
Buy | CLOVIS ONCOLOGY INCput | $7,538,000 | +5246.1% | 2,091 | +1930.1% | 0.28% | +3928.6% | |
Buy | HORIZON PHARMA PLCcall | $7,412,000 | +104.1% | 4,088 | +85.4% | 0.28% | +46.3% | |
Buy | CEMPRA INCcall | $7,306,000 | +188.2% | 3,019 | +96.4% | 0.27% | +107.6% | |
Buy | ACHILLION PHARMACEUTICALS INCcall | $7,322,000 | +145.3% | 9,039 | +136.2% | 0.27% | +75.6% | |
Buy | TENET HEALTHCARE CORPcall | $7,204,000 | +3116.1% | 3,179 | +3824.7% | 0.27% | +2150.0% | |
Buy | AMICUS THERAPEUTICS INCcall | $7,128,000 | +63.3% | 9,632 | +20.5% | 0.27% | +17.1% | |
Buy | OPHTHOTECH CORPcall | $6,998,000 | +279.9% | 1,517 | +320.2% | 0.26% | +172.9% | |
New | EXELIXIS INCput | $6,896,000 | – | 5,392 | +100.0% | 0.26% | – | |
New | KITE PHARMA INCput | $6,575,000 | – | 1,177 | +100.0% | 0.25% | – | |
New | AXOVANT SCIENCES LTDcall | $6,552,000 | – | 4,680 | +100.0% | 0.24% | – | |
Buy | LION BIOTECHNOLOGIES INCput | $6,503,000 | +6.7% | 7,901 | +5.0% | 0.24% | -23.3% | |
Buy | NEUROCRINE BIOSCIENCES INCcall | $6,148,000 | +66.4% | 1,214 | +49.3% | 0.23% | +19.2% | |
New | GILEAD SCIENCES INCput | $6,100,000 | – | 771 | +100.0% | 0.23% | – | |
Buy | KITE PHARMA INCcall | $6,044,000 | +42.0% | 1,082 | +27.1% | 0.23% | +1.8% | |
SHPG | Buy | SHIRE PLC | $6,043,000 | +11.1% | 31,172 | +5.5% | 0.23% | -20.4% |
Buy | HALOZYME THERAPEUTICS INCcall | $5,920,000 | +226.5% | 4,901 | +133.3% | 0.22% | +133.7% | |
Buy | ALNYLAM PHARMACEUTICALS INCput | $5,890,000 | +75.1% | 869 | +43.4% | 0.22% | +26.3% | |
Buy | PTC THERAPEUTICS INCcall | $5,589,000 | +357.7% | 3,989 | +129.3% | 0.21% | +226.6% | |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $5,474,000 | +29.2% | 521,875 | +79.6% | 0.20% | -7.2% |
Buy | LA JOLLA PHARMACEUTICAL COcall | $4,910,000 | +110.5% | 2,064 | +41.6% | 0.18% | +50.8% | |
New | HUMANA INCcall | $4,918,000 | – | 278 | +100.0% | 0.18% | – | |
Buy | AERIE PHARMACEUTICALS INCcall | $4,453,000 | +275.5% | 1,180 | +75.1% | 0.17% | +169.4% | |
CYTR | New | CYTRX CORP. | $4,368,000 | – | 7,424,786 | +100.0% | 0.16% | – |
New | SYNERGY PHARMACEUTICALS INC.call | $4,360,000 | – | 7,912 | +100.0% | 0.16% | – | |
Buy | AMARIN CORPORATION PLCcall | $4,354,000 | +114.2% | 13,648 | +45.0% | 0.16% | +53.8% | |
New | PUMA BIOTECHNOLOGY INCput | $4,311,000 | – | 643 | +100.0% | 0.16% | – | |
CELG | New | CELGENE CORP | $3,944,000 | – | 37,728 | +100.0% | 0.15% | – |
New | TENET HEALTHCARE CORPput | $3,952,000 | – | 1,744 | +100.0% | 0.15% | – | |
Buy | MANNKIND CORPput | $3,863,000 | -78.9% | 62,303 | +17.6% | 0.14% | -84.8% | |
Buy | GW PHARMACEUTICALS PLCcall | $3,624,000 | +130.1% | 273 | +58.7% | 0.14% | +65.9% | |
New | NOVO NORDISK A/Sput | $3,573,000 | – | 859 | +100.0% | 0.13% | – | |
OPGN | Buy | OPGEN INC. | $3,545,000 | +43.5% | 2,161,467 | +33.0% | 0.13% | +3.1% |
UTHR | New | UNITED THERAPEUTICS CORP | $3,319,000 | – | 28,112 | +100.0% | 0.12% | – |
EIGR | Buy | EIGER BIOPHARMACEUTICALS INC. | $3,090,000 | -11.0% | 230,803 | +31.7% | 0.12% | -35.9% |
TSRO | New | TESARO INC | $2,757,000 | – | 27,500 | +100.0% | 0.10% | – |
Buy | OPKO HEALTH INCcall | $2,638,000 | +89.4% | 2,491 | +67.1% | 0.10% | +35.6% | |
Buy | SANGAMO BIOSCIENCES INCcall | $2,598,000 | +2.0% | 5,611 | +27.5% | 0.10% | -27.1% | |
THC | New | TENET HEALTHCARE CORP | $2,557,000 | – | 112,831 | +100.0% | 0.10% | – |
New | GW PHARMACEUTICALS PLCput | $2,548,000 | – | 192 | +100.0% | 0.10% | – | |
Buy | REGENERON PHARMACEUTICALS INCcall | $2,533,000 | +68.6% | 63 | +46.5% | 0.10% | +21.8% | |
Buy | EXELIXIS INCcall | $2,468,000 | +77.2% | 1,930 | +8.2% | 0.09% | +26.0% | |
Buy | DERMIRA INCcall | $2,442,000 | +102.7% | 722 | +75.2% | 0.09% | +44.4% | |
Buy | HCA HOLDINGS INCput | $2,390,000 | +210.4% | 316 | +216.0% | 0.09% | +125.0% | |
SPHS | New | SOPHIRIS BIO INC. | $2,354,000 | – | 757,033 | +100.0% | 0.09% | – |
Buy | DERMIRA INCput | $2,293,000 | +171.4% | 678 | +134.6% | 0.09% | +95.5% | |
New | ENDO INTERNATIONAL PLCput | $2,208,000 | – | 1,096 | +100.0% | 0.08% | – | |
VXZ | New | BARCLAYS BANK PLCipath | $2,215,000 | – | 65,000 | +100.0% | 0.08% | – |
CDTX | Buy | CIDARA THERAPEUTICS INC. | $2,180,000 | +943.1% | 190,358 | +838.8% | 0.08% | +645.5% |
New | EXACT SCIENCES CORPput | $2,137,000 | – | 1,153 | +100.0% | 0.08% | – | |
VSAR | New | VERSARTIS INC. | $2,143,000 | – | 174,968 | +100.0% | 0.08% | – |
Buy | INSMED INCcall | $2,118,000 | +59.6% | 1,459 | +8.4% | 0.08% | +14.5% | |
New | SYNERGY PHARMACEUTICALS INC.put | $2,117,000 | – | 3,842 | +100.0% | 0.08% | – | |
RNN | Buy | REXAHN PHARMACEUTICALS INC | $1,988,000 | -12.8% | 9,464,849 | +4.3% | 0.07% | -37.8% |
New | PROTHENA CORPORATION PLCcall | $1,949,000 | – | 325 | +100.0% | 0.07% | – | |
ATNM | New | ACTINIUM PHARMACEUTICALS INC | $1,867,000 | – | 1,382,629 | +100.0% | 0.07% | – |
EDIT | New | EDITAS MEDICINE INC. | $1,820,000 | – | 135,000 | +100.0% | 0.07% | – |
Buy | INSMED INCput | $1,811,000 | +138.3% | 1,247 | +61.7% | 0.07% | +70.0% | |
NTLA | New | INTELLIA THERAPEUTICS INC | $1,784,000 | – | 104,841 | +100.0% | 0.07% | – |
New | AGENUS INCput | $1,795,000 | – | 2,500 | +100.0% | 0.07% | – | |
New | ACADIA PHARMACEUTICALS INCput | $1,743,000 | – | 548 | +100.0% | 0.06% | – | |
New | NEVRO CORPcall | $1,681,000 | – | 161 | +100.0% | 0.06% | – | |
Buy | AMICUS THERAPEUTICS INCput | $1,689,000 | +38.4% | 2,282 | +2.1% | 0.06% | -1.6% | |
HEB | New | HEMISPHERX BIOPHARMA INC. | $1,690,000 | – | 1,351,850 | +100.0% | 0.06% | – |
Buy | GLOBAL BLOOD THERAPEUTICS INCcall | $1,662,000 | +138.1% | 721 | +71.3% | 0.06% | +72.2% | |
CRME | New | CARDIOME PHARMA CORP | $1,521,000 | – | 484,505 | +100.0% | 0.06% | – |
RXDX | Buy | IGNYTA INC | $1,421,000 | +16.5% | 225,900 | +0.4% | 0.05% | -17.2% |
ONCS | Buy | ONCOSEC MEDICAL INC | $1,426,000 | +43.0% | 834,004 | +37.2% | 0.05% | +1.9% |
ITEK | Buy | INOTEK PHARMACEUTICALS CORP | $1,365,000 | +72.3% | 144,002 | +35.3% | 0.05% | +24.4% |
Buy | ACHILLION PHARMACEUTICALS INCput | $1,362,000 | +74.6% | 1,681 | +68.1% | 0.05% | +24.4% | |
MDGS | New | MEDIGUS LTD | $1,373,000 | – | 1,042,813 | +100.0% | 0.05% | – |
ONSIZ | Buy | ONCOBIOLOGICS INC*w | $1,332,000 | +579.6% | 926,651 | +112.1% | 0.05% | +400.0% |
Buy | THERAPEUTICSMD INCcall | $1,301,000 | +32.8% | 1,910 | +65.7% | 0.05% | -3.9% | |
DNAI | Buy | PRONAI THERAPEUTICS INC. | $1,252,000 | +6.6% | 687,734 | +16.6% | 0.05% | -23.0% |
Buy | ALCOBRA LTDcall | $1,192,000 | -40.6% | 4,826 | +8.0% | 0.04% | -57.1% | |
CAPR | Buy | CAPRICOR THERAPEUTICS INC. | $1,183,000 | +64.5% | 357,436 | +96.3% | 0.04% | +15.8% |
Buy | ACORDA THERAPEUTICS INCput | $1,176,000 | +361.2% | 563 | +463.0% | 0.04% | +238.5% | |
New | BIOCRYST PHARMACEUTICALS INCcall | $1,140,000 | – | 2,584 | +100.0% | 0.04% | – | |
CHEK | New | CHECK CAP LTD | $1,159,000 | – | 585,569 | +100.0% | 0.04% | – |
ONTXW | New | ONCONOVA THERAPEUTICS INC*w | $1,124,000 | – | 725,434 | +100.0% | 0.04% | – |
MNKD | New | MANNKIND CORP | $1,107,000 | – | 1,785,368 | +100.0% | 0.04% | – |
IMUCWS | New | IMMUNOCELLULAR THERAPEUTICS*w | $1,077,000 | – | 15,161,641 | +100.0% | 0.04% | – |
STML | New | STEMLINE THERAPEUTICS INC | $1,062,000 | – | 98,050 | +100.0% | 0.04% | – |
RIBT | Buy | RICEBRAN TECHNOLOGIES | $1,073,000 | -17.7% | 794,436 | +1.1% | 0.04% | -41.2% |
New | PACIRA PHARMACEUTICALS INCcall | $1,057,000 | – | 309 | +100.0% | 0.04% | – | |
CALA | New | CALITHERA BIOSCIENCES INC. | $1,055,000 | – | 324,500 | +100.0% | 0.04% | – |
Buy | RADIUS HEALTH INCcall | $1,055,000 | +82.8% | 195 | +24.2% | 0.04% | +33.3% | |
ONTX | New | ONCONOVA THERAPEUTICS INC | $1,039,000 | – | 392,023 | +100.0% | 0.04% | – |
DRWIQ | New | DRAGONWAVE INC. | $1,018,000 | – | 378,338 | +100.0% | 0.04% | – |
ONSIW | Buy | ONCOBIOLOGICS INC*w | $905,000 | +333.0% | 902,050 | +111.7% | 0.03% | +209.1% |
NSPRWS | New | INSPIREMD INC*w | $888,000 | – | 29,594,500 | +100.0% | 0.03% | – |
EYEG | Buy | EYEGATE PHARMACEUTICALS INC | $834,000 | -16.8% | 508,598 | +31.4% | 0.03% | -40.4% |
MDGN | Buy | MEDGENICS INC | $791,000 | +2.7% | 141,977 | +2.3% | 0.03% | -25.0% |
Buy | RADIUS HEALTH INCput | $763,000 | +73.0% | 141 | +17.5% | 0.03% | +26.1% | |
IMUC | Buy | IMMUNOCELLULAR THERAPEUTICS | $756,000 | -26.2% | 6,405,230 | +43.9% | 0.03% | -47.2% |
New | PORTOLA PHARMACEUTICALS INCcall | $681,000 | – | 300 | +100.0% | 0.03% | – | |
New | FOAMIX PHARMACEUTICALS LTDcall | $670,000 | – | 724 | +100.0% | 0.02% | – | |
Buy | ANTHERA PHARMACEUTICALS INCcall | $668,000 | +29.0% | 2,121 | +26.5% | 0.02% | -7.4% | |
MRTX | New | MIRATI THERAPEUTICS INC. | $659,000 | – | 99,735 | +100.0% | 0.02% | – |
Buy | ARBUTUS BIOPHARMA CORPcall | $670,000 | +187.6% | 1,949 | +191.3% | 0.02% | +108.3% | |
SCON | New | SUPERCONDUCTOR TECHNOLOGIES INC. | $669,000 | – | 250,474 | +100.0% | 0.02% | – |
Buy | TENAX THERAPEUTICS INCcall | $583,000 | +577.9% | 2,534 | +656.4% | 0.02% | +450.0% | |
New | BLUEPRINT MEDICINES CORPput | $564,000 | – | 190 | +100.0% | 0.02% | – | |
New | PACIRA PHARMACEUTICALS INCput | $544,000 | – | 159 | +100.0% | 0.02% | – | |
MDCO | Buy | MEDICINES CO | $510,000 | +117.0% | 13,508 | +93.0% | 0.02% | +58.3% |
NLNK | Buy | NEWLINK GENETICS CORP | $519,000 | +63.2% | 34,561 | +22.3% | 0.02% | +11.8% |
RNVA | New | RENNOVA HEALTH INC | $516,000 | – | 2,724,721 | +100.0% | 0.02% | – |
SSH | New | SUNSHINE HEART INC. | $518,000 | – | 908,021 | +100.0% | 0.02% | – |
New | TESARO INCput | $501,000 | – | 50 | +100.0% | 0.02% | – | |
New | COMMUNITY HEALTH SYSTEMS INCput | $477,000 | – | 413 | +100.0% | 0.02% | – | |
New | INOTEK PHARMACEUTICALS CORPput | $474,000 | – | 500 | +100.0% | 0.02% | – | |
Buy | BIODELIVERY SCIENCES INTERNATIONAL INCcall | $478,000 | +24.5% | 1,770 | +8.9% | 0.02% | -10.0% | |
CMRX | New | CHIMERIX INC. | $443,000 | – | 79,900 | +100.0% | 0.02% | – |
CBMXW | Buy | COMBIMATRIX CORP.*w | $429,000 | -25.1% | 857,746 | +0.3% | 0.02% | -46.7% |
NUROW | Buy | NEUROMETRIX INC*w | $400,000 | -34.6% | 3,060,947 | +0.0% | 0.02% | -53.1% |
New | LION BIOTECHNOLOGIES INCcall | $408,000 | – | 496 | +100.0% | 0.02% | – | |
New | FLEXION THERAPEUTICS INCput | $395,000 | – | 202 | +100.0% | 0.02% | – | |
AVXS | New | AVEXIS ORD SHS | $412,000 | – | 10,000 | +100.0% | 0.02% | – |
New | THERAPEUTICSMD INCput | $399,000 | – | 586 | +100.0% | 0.02% | – | |
New | BENITEC BIOPHARMA LTDadr | $385,000 | – | 274,573 | +100.0% | 0.01% | – | |
New | ACORDA THERAPEUTICS INCcall | $374,000 | – | 179 | +100.0% | 0.01% | – | |
New | FIBROGEN INCcall | $339,000 | – | 164 | +100.0% | 0.01% | – | |
CYH | New | COMMUNITY HEALTH SYSTEMS INC | $359,000 | – | 31,122 | +100.0% | 0.01% | – |
Buy | AMARIN CORPORATION PLCput | $358,000 | +48.5% | 1,121 | +0.3% | 0.01% | 0.0% | |
New | INCYTE CORPcall | $339,000 | – | 36 | +100.0% | 0.01% | – | |
NURO | Buy | NEUROMETRIX INC | $338,000 | +18.2% | 219,336 | +27.3% | 0.01% | -13.3% |
New | ANAVEX LIFE SCIENCES CORPput | $311,000 | – | 858 | +100.0% | 0.01% | – | |
New | MEDGENICS INCcall | $297,000 | – | 533 | +100.0% | 0.01% | – | |
DRNA | New | DICERNA PHARMACEUTICALS INC | $294,000 | – | 50,000 | +100.0% | 0.01% | – |
QRHC | New | QUEST RESOURCE HOLDING CORP | $281,000 | – | 138,980 | +100.0% | 0.01% | – |
RNVAW | New | RENNOVA HEALTH INC*w | $258,000 | – | 3,682,014 | +100.0% | 0.01% | – |
OCUL | New | OCULAR THERAPEUTIX INC | $262,000 | – | 38,100 | +100.0% | 0.01% | – |
New | SYNERGY PHARMACEUTICALS INC.*w | $268,000 | – | 348,743 | +100.0% | 0.01% | – | |
New | AETERNA ZENTARIS INCput | $254,000 | – | 740 | +100.0% | 0.01% | – | |
APOP | New | CELLECT BIOTECHNOLOGY LTDads | $264,000 | – | 57,348 | +100.0% | 0.01% | – |
New | STEMLINE THERAPEUTICS INCcall | $240,000 | – | 222 | +100.0% | 0.01% | – | |
Buy | DURECT CORPcall | $245,000 | +160.6% | 1,759 | +128.4% | 0.01% | +80.0% | |
TXMD | New | THERAPEUTICSMD INC | $232,000 | – | 34,030 | +100.0% | 0.01% | – |
Buy | NATERA INCcall | $161,000 | -7.5% | 145 | +0.7% | 0.01% | -33.3% | |
SGMO | New | SANGAMO BIOSCIENCES INC | $152,000 | – | 32,804 | +100.0% | 0.01% | – |
EVOK | New | EVOKE PHARMA INC. | $144,000 | – | 63,768 | +100.0% | 0.01% | – |
New | SORRENTO THERAPEUTICS INCcall | $127,000 | – | 164 | +100.0% | 0.01% | – | |
Buy | ALCOBRA LTDput | $138,000 | -25.0% | 559 | +36.7% | 0.01% | -50.0% | |
Buy | INVIVO THERAPEUTICS HOLDINGS CORPcall | $135,000 | +132.8% | 199 | +99.0% | 0.01% | +66.7% | |
New | INOTEK PHARMACEUTICALS CORPcall | $100,000 | – | 106 | +100.0% | 0.00% | – | |
Buy | ATHERSYS INCput | $101,000 | +106.1% | 476 | +111.6% | 0.00% | +33.3% | |
PVCT | Buy | PROVECTUS BIOPHARMACEUTICALS INC | $107,000 | +205.7% | 1,077,555 | +1055.1% | 0.00% | +100.0% |
New | GALECTIN THERAPEUTICS INCput | $93,000 | – | 825 | +100.0% | 0.00% | – | |
New | ASTERIAS BIOTHERAPEUTICS INCcall | $85,000 | – | 200 | +100.0% | 0.00% | – | |
NSPR | New | INSPIREMD INC | $54,000 | – | 679,224 | +100.0% | 0.00% | – |
Buy | EDAP TMS S Aput | $53,000 | +1.9% | 182 | +15.9% | 0.00% | -33.3% | |
GALE | Buy | GALENA BIOPHARMA INC | $49,000 | -7.5% | 141,000 | +24.2% | 0.00% | -33.3% |
GPL | New | GREAT PANTHER SILVER LTD | $55,000 | – | 40,450 | +100.0% | 0.00% | – |
New | ADAMIS PHARMACEUTICALS CORPput | $51,000 | – | 148 | +100.0% | 0.00% | – | |
Buy | ZAFGEN INCcall | $15,000 | -97.3% | 2,149 | +131.1% | 0.00% | -96.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.